Valbiotis
ISIN: FR0013254851 | Ticker: ALVAL | LEI: 969500VP4JBJCF0MOP60
Country: France
Valbiotis is a Research & Development company dedicated to scientific innovation for preventing and combating metabolic and cardiovascular diseases.
To achieve this goal, Valbiotis has developed an exclusive and unique scientific approach founded on specific combinations of plant-based molecules. The active substances, which are called “Totum”, act directly on the key metabolic parameters of the body. Our unique approach focuses on prevention by providing health nutrition solutions.
2014
Served areaWorldwide
Headcount47
HeadquartersZI des Quatre Chevaliers 12F Rue Paul Vatine, 17180 Périgny – France
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 17.01.23 | None | Other | Other | EUR 46,072.00 |
FR0013254851
LEI969500VP4JBJCF0MOP60
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.